An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...
Hypertrophic cardiomyopathy (HCM) causes heart muscle thickening that may lead to obstructed blood flow. Symptoms include ...
Verywell Health on MSN13d
Cardiomegaly and Treatment of an Enlarged HeartMedically reviewed by Yasmine S. Ali, MD, MSCI Cardiomegaly is the term used to describe an enlarged heart. It is most ...
Inclusion body myositis (IBM) is an inflammatory myopathy causing proximal and distal muscle weakness. IBM’s cause remains ...
The Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment of Duchenne muscular dystrophy (DMD) ...
as a treatment for patients diagnosed with Duchenne muscular dystrophy ("DMD") cardiomyopathy. The FDA granted the BLA Priority Review with a Prescription Drug User Fee Act ("PDUFA") target ...
A new 27-protein model accurately detects cardiomyopathy risk in childhood cancer survivors, aiding early intervention and ...
Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback